LSE - Delayed Quote GBp
Beximco Pharmaceuticals Limited (BXP.L)
40.00
+2.00
+(5.26%)
At close: April 23 at 12:54:39 PM GMT+1
Breakdown
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Assets
69,344,022.64
69,156,783.25
66,148,035.74
52,246,084.03
Total Liabilities Net Minority Interest
17,441,119.76
21,537,117.27
21,512,031.28
14,881,219.20
Total Equity Gross Minority Interest
51,902,902.88
47,619,665.98
44,636,004.46
37,364,864.83
Total Capitalization
49,383,216.78
45,838,420.76
43,597,925.08
38,003,254.67
Common Stock Equity
47,949,964.74
43,680,703.74
40,600,497.82
37,030,558.20
Capital Lease Obligations
464,014.90
539,638.07
617,340.62
347,996.90
Net Tangible Assets
42,554,697.68
38,285,098.92
35,196,089.22
35,103,173.18
Working Capital
11,255,597.58
7,610,830.20
5,683,326.21
4,421,167.77
Invested Capital
53,511,380.57
53,752,964.36
52,353,858.84
44,313,865.54
Tangible Book Value
42,554,697.68
38,285,098.92
35,196,089.22
35,103,173.18
Total Debt
6,025,430.73
10,611,898.69
12,370,701.63
7,631,304.24
Net Debt
4,707,310.18
8,936,574.45
10,584,687.20
6,607,840.73
Share Issued
446,112.09
446,112.09
446,112.09
446,112.09
Ordinary Shares Number
446,112.09
446,112.09
446,112.09
446,112.09
6/30/2021 - 10/21/2005
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade